Hannah Freeman

2.6k citations
23 papers · 1.8k · 5 hit papers · h-index 11

Impact in

Papers in

    • Cancer survivorship and care 4
    • COVID-19 and healthcare impacts 2
    • SARS-CoV-2 and COVID-19 Research 3
    • COVID-19 Clinical Research Studies 1

Hannah Freeman

22 papers receiving 1.7k citations

Hannah Freeman's Hit Papers

Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis 2022 · 230 citations
2300+1+3Years since publication100200300400

Peers

Hannah Freeman
Comparison fields: 5 of 116
  • Infectious Diseases 969
  • Applied Microbiology and Biotechnology 50
  • Neurology 345
  • Internal Medicine 60
  • Obstetrics and Gynecology 87
Replace Matthew William Maycock with:
Matthew William Maycock United Kingdom
Helen Membrey United Kingdom
Mim Evans United Kingdom
Amy Marie Campbell United Kingdom
Kristen Hunt Australia
Katie Gregory United States
Nicky Leopold United Kingdom
Krishnan Aniruddhan United Kingdom
Vashist Deelchand United Kingdom
Andrew Blythe United Kingdom
Hannah Freeman relative to Matthew William Maycock United Kingdom Matthew William Maycock's profile →
Citations per field
00.5×2×3×
Matthew William Maycock · 1×
Citations per year

Countries citing papers authored by Hannah Freeman

Since Specialization
Citations

This map shows the geographic impact of Hannah Freeman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hannah Freeman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hannah Freeman more than expected).

Fields of papers citing papers by Hannah Freeman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hannah Freeman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hannah Freeman. The network helps show where Hannah Freeman may publish in the future.

Co-authors

The 25 scholars most cited alongside Hannah Freeman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Hannah Freeman Line = papers co-authored together Hannah Freeman links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 23 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
Hit paper breakdown →
2021403
2
Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial
Hit paper breakdown →
2021381
3
Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
Hit paper breakdown →
2022282
4
Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis
Hit paper breakdown →
2022230
5
Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
Hit paper breakdown →
2021211
6 1994111
7 202383
8 201428
9 202324
10 202423
11 202116
12 20147
13 20216
14 20246
15 20255
16 20234
17 20233
18 20242
19 20252
20
Impact of cancer history on outcomes among hospitalized COVID-19 patients: A case-control analysis
20201

About Hannah Freeman

Hannah Freeman is a scholar working on Oncology, Infectious Diseases, General Health Professions, Cardiology and Cardiovascular Medicine and Virology, having authored 23 papers that have together received 1.8k indexed citations. Recurring topics across this work include Cancer survivorship and care (4 papers), SARS-CoV-2 and COVID-19 Research (3 papers), COVID-19 and healthcare impacts (2 papers), Cardiac, Anesthesia and Surgical Outcomes (2 papers), Gambling Behavior and Treatments (1 paper), COVID-19 Clinical Research Studies (1 paper), Rabies epidemiology and control (1 paper) and Lipoproteins and Cardiovascular Health (1 paper). The work is most often cited by research in Infectious Diseases (969 citations), Applied Microbiology and Biotechnology (50 citations), Neurology (345 citations), Internal Medicine (60 citations) and Obstetrics and Gynecology (87 citations). Hannah Freeman has collaborated with scholars based in United Kingdom, United States and Australia. Frequent co-authors include Bonnie T. Zima, Kenneth Brooks Wells, William Eardley, Shoshana M. Rosenberg, Tal Sella, Philip Daniel Poorvu, Ann H. Partridge, Ian C. C. King, Shirlene D. Wang and Isaac A. Klein. Their work appears in journals such as The Lancet, Supportive Care in Cancer, JCO Clinical Cancer Informatics, Nature Communications and International Journal of Surgery.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact